# Effect of OC459 on the Response to Rhinovirus Challenge in Asthma

> **NCT02660489** · PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 44 (actual)

## Conditions studied

- Asthma
- Rhinovirus
- Picornaviridae Infections
- Common Cold

## Interventions

- **DRUG:** OC459
- **DRUG:** Placebo
- **OTHER:** Rhinovirus

## Key facts

- **NCT ID:** NCT02660489
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-02-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02660489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02660489, "Effect of OC459 on the Response to Rhinovirus Challenge in Asthma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02660489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*